1. Home
  2. AEHL vs MBRX Comparison

AEHL vs MBRX Comparison

Compare AEHL & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antelope Enterprise Holdings Limited

AEHL

Antelope Enterprise Holdings Limited

HOLD

Current Price

$5.69

Market Cap

8.6M

Sector

Industrials

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$0.44

Market Cap

9.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHL
MBRX
Founded
1993
2015
Country
China
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6M
9.6M
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
AEHL
MBRX
Price
$5.69
$0.44
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$61.00
AVG Volume (30 Days)
6.1M
1.8M
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.16
52 Week High
$5.89
$7.98

Technical Indicators

Market Signals
Indicator
AEHL
MBRX
Relative Strength Index (RSI) 90.42 18.93
Support Level $0.72 $0.28
Resistance Level $5.89 $0.57
Average True Range (ATR) 0.40 0.22
MACD 0.32 -0.11
Stochastic Oscillator 61.25 13.13

Price Performance

Historical Comparison
AEHL
MBRX

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: